תרומין 40 מ"ג - Taromine 40 mg
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ××× ×× ×× × ×ספ×× | |
|---|---|
| ×§×××¦× ×¤×¨××§×××××ת (ATC4) | N06BA Centrally acting sympathomimetics |
| ×ר××× ×¤×¢×× (ATC5) | Â
|
| צ×רת ××ª× | פ××× - PER OS |
| צ×רת ××× ×× | קפס×××ת, CAPSULES ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× |
| ×ת×××× | Taromine is a central nervous system (CNS) stimulant indicated for:⢠the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients ages 6 years and above.⢠the treatment of Moderate to Severe Binge Eating Disorder (BED) for patients over 18 years.Limitation of Use:Taromine is not indicated or recommended for weight loss. Use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. The safety and effectiveness of Taromine for the treatment of obesity have not been established. |
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
 ××× ×¢××× ×ר××¤× Â |
| ×¢××× ×צר×× |  |
|---|
| ער××× ×××××§×רפ××× | ער××× ×§×©×ר×× ×××××§×רפ××× |
|---|---|
| תר×××× 40 ×"× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | SUN PHARMACEUTICAL INDUSTRIES LTD., INDIA |
| ×©× ××¢× ×ר×ש×× | TARO INTERNATIONAL LTD, ISRAEL |
| ר×ש××× | ת×ר×× ××ש×: 11/2023. ר×ש××× ×ת×ר××: |
| ת×ר×× ×¢×××× ××ר×× | 23/08/2024 |
השינוי האחרון נעשה בֹ־23 באוגוסט 2024 ב־04:26